
Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera.
New York-based Pfizer said Friday after markets closed that it was suing Metsera and a third drugmaker, Denmark’s Novo Nordisk, over a bid for Metsera that Novo announced Thursday.